Evidence map›Paper›PMID 16091750›Full record

ArticleOncogene2005

BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.

Valeriu B Cismasiu, Karen Adamo, Jennifer Gecewicz, Javier Duque, Qishan Lin, Dorina Avram

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 167 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. UsingBiology · 2023
    Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Valeriu B CismasiuCenter for Cell Biology and Cancer Research, Albany Medical College, 47 New Scotland Avenue, MC-165, Albany, NY 12208, USA.
Karen Adamo
Jennifer Gecewicz
Javier Duque
Qishan Lin
Dorina Avram
Albany Medical Center Hospital · USUniversity at Albany, State University of New York · US

Funding

A Novel Zinc Finger Transcriptional Modulator Of T CellsK01AR002194 · NIAMS · OREGON STATE UNIVERSITY · PI AVRAM, DORINA · 2001 to 2005
$565k
NIAMS NIH HHS K01-AR02194
6 · The paper itself

Abstract

BCL11 genes play crucial roles in lymphopoiesis and have been associated with hematopoietic malignancies. Specifically, disruption of the BCL11B (B-cell chronic lymphocytic leukemia/lymphoma 11B) locus is linked to T-cell acute lymphoblastic leukemia, and the loss of heterozygosity in mice results in T-cell lymphoma. BCL11 proteins are related C2H2 zinc-finger transcription factors that act as transcriptional repressors. Here, we demonstrate the association of the endogenous BCL11B with the nucleosome remodeling and histone deacetylase (NuRD) complex, one of the major transcriptional corepressor complexes in mammalian cells. BCL11B complexes from T lymphocytes possess trichostatin A-sensitive histone deacetylase activity, confirming the functionality of the complexes. Analysis of the BCL11B-NuRD association demonstrated that BCL11B directly interacted with the metastasis-associated proteins MTA1 and MTA2 through the amino-terminal region. We provide evidence for the functional requirement of MTA1 in transcriptional repression mediated by BCL11B through the following: (1) overexpression of MTA1 enhanced the transcriptional repression mediated by BCL11B, (2) knockdown of MTA1 expression by small interfering RNA inhibited BCL11B transcriptional repression activity and (3) MTA1 was specifically recruited to a BCL11B targeted promoter. Taken together, these data support the hypothesis that the NuRD complex mediates transcriptional repression function of BCL11B.

Indexed as

Promoter Regions, GeneticAmino Acid SequenceAnimalsCD4-Positive T-LymphocytesCell LineDNA-Binding ProteinsHistone DeacetylasesHumansHydroxamic AcidsMi-2 Nucleosome Remodeling and Deacetylase ComplexMolecular Sequence DataRepressor ProteinsTumor Suppressor ProteinsBCL11B protein, humanDNA-Binding ProteinsHistone DeacetylasesHydroxamic AcidsMi-2 Nucleosome Remodeling and Deacetylase ComplexRepressor Proteinstrichostatin ATumor Suppressor Proteins

Identifiers

PMID16091750
OpenAlexW2142057312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.